BTG Pactual Global Asset Management’s Ligand Pharmaceuticals LGND Stock Holding History

BTG Pactual Global Asset Management’s Portfolio LGND Stock Details LGND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-5,931	Closed	-$373K	–	188
2015 Q2	$373K	Buy	+5,931	New	+$324K	0.02%	167
2014 Q4	–	Sell	-7,053	Closed	-$207K	–	202
2014 Q3	$207K	Hold	7,053	–	–	0.02%	201
2014 Q2	$274K	Buy	7,053 +2,036	+41%	+$82.6K	0.04%	210
2014 Q1	$211K	Buy	+5,017	New	+$209K	0.05%	162

Other funds holding LGND

RIM

RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

DMK

David M. Knott $275M AUM 59.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ORI

Oak Ridge Investments Chicago, Illinois $1.77B AUM 63.16% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

CCMLC

Cardinal Capital Management LLC (Connecticut) Greenwich, Connecticut $365M AUM 18.32% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

BTG Pactual Global Asset Management's LGND Position: Q3 2015 in Review

BTG Pactual Global Asset Management sold out of Ligand Pharmaceuticals (LGND) in Q3 2015, closing a stake of 5,931 shares — an estimated $373K sold.

BTG Pactual Global Asset Management first reported a position in LGND in Q1 2014 and held it in 4 quarters. The position peaked at $373K in Q2 2015. 203 funds tracked by Wall St. Rank hold LGND as of Q3 2015.

BTG Pactual Global Asset Management reported no remaining Ligand Pharmaceuticals position as of Q3 2015 after selling out during the quarter.
BTG Pactual Global Asset Management sold 5,931 Ligand Pharmaceuticals shares in Q3 2015, an estimated $373K.
BTG Pactual Global Asset Management first reported a position in Ligand Pharmaceuticals in Q1 2014 and held it in 4 quarters.
BTG Pactual Global Asset Management's Ligand Pharmaceuticals position peaked at $373K in Q2 2015.
203 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q3 2015.

Based on BTG Pactual Global Asset Management's 13F filing for Q3 2015, filed 13 Nov 2015.